Actively Recruiting

Age: 21Years +
All Genders
NCT06967792

Evaluation of the Safety of Terahertz Scanning System on Corneas

Led by Singapore Eye Research Institute · Updated on 2025-05-16

5

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational study aims to establish the safety profile of the use of Terahertz (THz) scanning system on corneal diseases. Participants with "non-seeing" eyes but normal corneas will undergo THz scanning. Eye examinations will be conducted at baseline, immediately after scanning, and at 1 day, 1 week, and 1 month post-scanning. These examinations will include measurements of visual acuity, eye structural, retinal health, corneal cell morphology, and corneal nerve status. The investigators hypothesize that the THz scanning system is safe for application to the human cornea.

CONDITIONS

Official Title

Evaluation of the Safety of Terahertz Scanning System on Corneas

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be at least 21 years of age
  • Any gender (male or female)
  • Any race (Chinese, Malay, Indian, Eurasian, others)
  • Willing and able to follow all study instructions and attend scheduled visits
  • Have at least one eye that is functionally blind but has a healthy cornea
  • Able to keep face sufficiently stable for necessary scans
  • Best spectacle corrected visual acuity (BSCVA) in the study eye of hand motion or worse
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women
  • Eyes with previous major corneal surgery such as corneal transplantation, refractive surgery, or corneal cross-linking
  • Eyes with previous infectious keratitis
  • Eyes with long-term use of glaucoma eye drops
  • Eyes with known moderate or severe meibomian gland dysfunction
  • Eyes with active inflammation, infection, or chronic ocular surface inflammation
  • Systemic diseases affecting the ocular surface, such as systemic autoimmune diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Singapore National Eye Centre

Singapore, Singapore, Singapore, S169856

Actively Recruiting

Loading map...

Research Team

Y

Yu-Chi Liu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here